143 related articles for article (PubMed ID: 37951789)
1. Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis.
Russo RC; Quesniaux VFJ; Ryffel B
Trends Immunol; 2023 Dec; 44(12):1014-1030. PubMed ID: 37951789
[TBL] [Abstract][Full Text] [Related]
2. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
3. CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential.
Liu S; Liu C; Wang Q; Liu S; Min J
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830702
[TBL] [Abstract][Full Text] [Related]
4. [Pirfenidone Inhibits Cytokines/chemokines Release from Alveolar Macrophages].
Long X; Tang Y; Li J; Wang W; Ou D; Xu L; He J; Xie L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Oct; 42(5):596-602. PubMed ID: 33131513
[TBL] [Abstract][Full Text] [Related]
5. Alveolar macrophages drive lung fibroblast function in cocultures of IPF and normal patient samples.
Novak CM; Sethuraman S; Luikart KL; Reader BF; Wheat JS; Whitson B; Ghadiali SN; Ballinger MN
Am J Physiol Lung Cell Mol Physiol; 2023 Apr; 324(4):L507-L520. PubMed ID: 36791050
[TBL] [Abstract][Full Text] [Related]
6. S100a4 Is Secreted by Alternatively Activated Alveolar Macrophages and Promotes Activation of Lung Fibroblasts in Pulmonary Fibrosis.
Zhang W; Ohno S; Steer B; Klee S; Staab-Weijnitz CA; Wagner D; Lehmann M; Stoeger T; Königshoff M; Adler H
Front Immunol; 2018; 9():1216. PubMed ID: 29910813
[TBL] [Abstract][Full Text] [Related]
7. A novel therapeutic approach for IPF: Based on the "Autophagy - Apoptosis" balance regulation of Zukamu Granules in alveolar macrophages.
Li S; Liu G; Gu M; Li Y; Li Y; Ji Z; Li K; Wang Y; Zhai H; Wang Y
J Ethnopharmacol; 2022 Oct; 297():115568. PubMed ID: 35868548
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.
Hewlett JC; Kropski JA; Blackwell TS
Matrix Biol; 2018 Oct; 71-72():112-127. PubMed ID: 29625182
[TBL] [Abstract][Full Text] [Related]
9. Multiomic analysis of monocyte-derived alveolar macrophages in idiopathic pulmonary fibrosis.
Zhang M; Zhang J; Hu H; Zhou Y; Lin Z; Jing H; Sun B
J Transl Med; 2024 Jun; 22(1):598. PubMed ID: 38937806
[TBL] [Abstract][Full Text] [Related]
10. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis.
Allden SJ; Ogger PP; Ghai P; McErlean P; Hewitt R; Toshner R; Walker SA; Saunders P; Kingston S; Molyneaux PL; Maher TM; Lloyd CM; Byrne AJ
Am J Respir Crit Care Med; 2019 Jul; 200(2):209-219. PubMed ID: 31051082
[No Abstract] [Full Text] [Related]
11. Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis.
Martin-Medina A; Lehmann M; Burgy O; Hermann S; Baarsma HA; Wagner DE; De Santis MM; Ciolek F; Hofer TP; Frankenberger M; Aichler M; Lindner M; Gesierich W; Guenther A; Walch A; Coughlan C; Wolters P; Lee JS; Behr J; Königshoff M
Am J Respir Crit Care Med; 2018 Dec; 198(12):1527-1538. PubMed ID: 30044642
[No Abstract] [Full Text] [Related]
12. Alveolar epithelial cells in idiopathic pulmonary fibrosis display upregulation of TRAIL, DR4 and DR5 expression with simultaneous preferential over-expression of pro-apoptotic marker p53.
Akram KM; Lomas NJ; Forsyth NR; Spiteri MA
Int J Clin Exp Pathol; 2014; 7(2):552-64. PubMed ID: 24551275
[TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation.
Lee J; Arisi I; Puxeddu E; Mramba LK; Amicosante M; Swaisgood CM; Pallante M; Brantly ML; Sköld CM; Saltini C
PLoS One; 2018; 13(4):e0194803. PubMed ID: 29649237
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and immunity in IPF pathogenesis and treatment.
Heukels P; Moor CC; von der Thüsen JH; Wijsenbeek MS; Kool M
Respir Med; 2019 Feb; 147():79-91. PubMed ID: 30704705
[TBL] [Abstract][Full Text] [Related]
16. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis.
Lv J; Gao H; Ma J; Liu J; Tian Y; Yang C; Li M; Zhao Y; Li Z; Zhang X; Zhu Y; Zhang J; Wu L
Front Immunol; 2023; 14():1230266. PubMed ID: 37771586
[TBL] [Abstract][Full Text] [Related]
17. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.
Kass DJ; Yu G; Loh KS; Savir A; Borczuk A; Kahloon R; Juan-Guardela B; Deiuliis G; Tedrow J; Choi J; Richards T; Kaminski N; Greenberg SM
Am J Pathol; 2012 May; 180(5):1963-78. PubMed ID: 22429962
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
